How can elderly apolipoprotein E ε4 carriers remain free from dementia?

Neurobiology of Aging

Volumn 34, Issue 1, 2013, Pages 13-21

  Ferrari, Camilla ^a,b   Xu, Wei Li ^a,c   Wang, Hui Xin ^a   Winblad, Bengt ^a   Sorbi, Sandro ^b   Qiu, Chengxuan ^a   Fratiglioni, Laura ^a,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF FLORENCE   (Italy)

^c TIANJIN MEDICAL UNIVERSITY   (China)

^d STOCKHOLM GERONTOLOGY RESEARCH CENTER   (Sweden)

Author keywords

Alzheimer's disease; APOE 4 allele; Dementia; Education; Hazard ratio; Leisure activities; Prospective cohort study; Vascular risk factors

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALLELE; ALZHEIMER DISEASE; APOLIPOPROTEIN E EPSILON 4 GENE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; EDUCATIONAL STATUS; ELDERLY CARE; FEMALE; FOLLOW UP; GENE; GENETIC RISK; GENOTYPE; HAZARD RATIO; HETEROZYGOTE; HUMAN; LEISURE; MALE; MENTAL PERFORMANCE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SOCIAL BEHAVIOR;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; DEMENTIA; EDUCATIONAL STATUS; FEMALE; GENOTYPE; HUMANS; KAPLAN-MEIER ESTIMATE; LEISURE ACTIVITIES; LONGITUDINAL STUDIES; MALE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; VASCULAR DISEASES;

EID: 84868120880     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.03.003     Document Type: Article

References (52)

1. Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition-Revised (DSM-III-R) 1987, American Psychiatric Association, American Psychiatric Association, Washington, DC.
2. Basun H., Corder E.H., Guo Z., Lannfelt L., Corder L.S., Manton K.G., Winblad B., Viitanen M. Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more. Stroke 1996, 27:1310-1315.
3. Bennett D.A., Wilson R.S., Schneider J.A., Evans D.A., Mendes de Leon C.F., Arnold S.E., Barnes L.L., Bienias J.L. Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology 2003, 60:1909-1915.
4. Bertram L., McQueen M.B., Mullin K., Blacker D., Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet 2007, 39:17-23.
5. Carmelli D., Swan G.E., Reed T., Miller B., Wolf P.A., Jarvik G.P., Schellenberg G.D. Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins. Neurology 1998, 50:1580-1585.
6. Corbo R.M., Scacchi R. Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a "thrifty" allele?. Ann. Hum. Genet 1999, 63:301-310.
7. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997, 278:1349-1356.
8. Fratiglioni L., Grut M., Forsell Y., Viitanen M., Winblad B. Clinical diagnosis of Alzheimer's disease and other dementias in a population survey. Agreement and causes of disagreement in applying Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition, Criteria. Arch. Neurol 1992, 49:927-932.
9. Fratiglioni L., Launer L.J., Andersen K., Breteler M.M., Copeland J.R., Dartigues J.F., Lobo A., Martinez-Lage J., Soininen H., Hofman A. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000, 54(11 suppl 5):S10-S15.
10. Fratiglioni L., Viitanen M., Backman L., Sandman P.O., Winblad B. Occurrence of dementia in advanced age: the study design of the Kungsholmen Project. Neuroepidemiology 1992, 11(suppl 1):29-36.
11. Fratiglioni L., Viitanen M., von Strauss E., Tontodonati V., Herlitz A., Winblad B. Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology 1997, 48:132-138.
12. Fratiglioni L., Wang H.X. Brain reserve hypothesis in dementia. J. Alzheimers Dis 2007, 12:11-22.
13. Fratiglioni L., Winblad B., von Strauss E. Prevention of Alzheimer's disease and dementia. Major findings from the Kungsholmen Project. Physiol. Behav 2007, 92:98-104.
14. Gee J.R., Keller J.N. Astrocytes: regulation of brain homeostasis via apolipoprotein E. Int. J. Biochem. Cell Biol 2005, 37:1145-1450.
15. Guo Z., Fratiglioni L., Viitanen M., Lannfelt L., Basun H., Fastbom J., Winblad B. Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: variation by use of antihypertensive medication?. Am. J. Epidemiol 2001, 153:225-231.
16. Hofman A., Ott A., Breteler M.M., Bots M.L., Slooter A.J., van Harskamp F., van Duijn C.N., Van Broeckhoven C., Grobbee D.E. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997, 349:151-154. 10.1016/S0140-6736(96)09328-2.
17. Huang Y., Weisgraber K.H., Mucke L., Mahley R.W. Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease. J. Mol. Neurosci 2004, 23:189-204. 10.1385/JMN:23:3:189.
18. Kalmijn S., Feskens E.J., Launer L.J., Kromhout D. Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men. Stroke 1996, 27:2230-2235.
19. Karp A., Paillard-Borg S., Wang H.X., Silverstein M., Winblad B., Fratiglioni L. Mental, physical and social components in leisure activities equally contribute to decrease dementia risk. Dement. Geriatr. Cogn. Disord 2006, 21:65-73.
20. Khachaturian A.S., Corcoran C.D., Mayer L.S., Zandi P.P., Breitner J.C. Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: the Cache County Study. Arch. Gen. Psychiatry 2004, 61:518-524.
21. Laws S.M., Hone E., Gandy S., Martins R.N. Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. J. Neurochem 2003, 84:1215-1236.
22. Myers R.H., Schaefer E.J., Wilson P.W., D'Agostino R., Ordovas J.M., Espino A., Au R., White R.F., Knoefel J.E., Cobb J.L., McNulty K.A., Beiser A., Wolf P.A. Apolipoprotein E ε4 association with dementia in a population-based study: the Framingham Study. Neurology 1996, 46:673-677.
23. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
24. Middleton L.E., Yaffe K. Targets for the prevention of dementia. J. Alzheimers Dis 2009, 20:915-924.
25. Miyata M., Smith J.D. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat. Genet 1996, 14:55-61.
26. Ngandu T., von Strauss E., Helkala E.L., Winblad B., Nissinen A., Tuomilehto J., Soininen H., Kivipelto M. Education and dementia: what lies behind the association?. Neurology 2007, 69:1442-1450.
27. Noguchi S., Murakami K., Yamada N. Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993, 342:737. 10.1016/0140-6736(93)91728-5.
28. Olichney J.M., Hansen L.A., Galasko D., Saitoh T., Hofstetter C.R., Katzman R., Thal L.J. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 1996, 47:190-196.
29. Padyukov L., Silva C., Stolt P., Alfredsson L., Klareskog L. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 2004, 50:3085-3092.
30. Peila R., White L.R., Petrovich H., Masaki K., Ross G.W., Havlik R.J., Launer L.J. Joint effect of the APOE gene and midlife systolic blood pressure on late-life cognitive impairment: the Honolulu-Asia aging study. Stroke 2001, 32:2882-2889.
31. Podewils L.J., Guallar E., Kuller L.H., Fried L.P., Lopez O.L., Carlson M., Lyketsos C.G. Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. Am. J. Epidemiol 2005, 161:639-651.
32. Polvikoski T., Sulkava R., Haltia M., Kainulainen K., Vuorio A., Verkkoniemi A., Niinistö L., Halonen P., Kontula K. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. N. Engl. J. Med. 1995, 333:1242-1247.
33. Qiu C., Bäckman L., Winblad B., Agüero-Torres H., Fratiglioni L. The influence of education on clinically diagnosed dementia incidence and mortality data from the Kungsholmen Project. Arch. Neurol 2001, 58:2034-2039.
34. Qiu C., Kivipelto M., Aguero-Torres H., Winblad B., Fratiglioni L. Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex. J. Neurol. Neurosurg., Psychiatry 2004, 75:828-833.
35. Qiu C., von Strauss E., Fastbom J., Winblad B., Fratiglioni L. Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Arch. Neurol 2003, 60:223-228.
36. Qiu C., Winblad B., Marengoni A., Klarin I., Fastbom J., Fratiglioni L. Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study. Arch. Intern. Med 2006, 166:1003-1008.
37. Qiu C., Xu W., Winblad B., Fratiglioni L. Vascular risk profiles for dementia and Alzheimer's disease in very old people: a population-based longitudinal study. J. Alzheimers Dis 2010, 20:293-300.
38. Rosvall L., Rizzuto D., Wang H.X., Winblad B., Graff C., Fratiglioni L. APOE-related mortality: effect of dementia, cardiovascular disease and gender. Neurobiol. Aging 2009, 30:1545-1551.
39. Rovio S., Kåreholt I., Helkala E.L., Viitanen M., Winblad B., Tuomilehto J., Soininen H., Nissinen A., Kivipelto M. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol 2005, 4:705-711. 10.1016/S1474-4422(05)70198-8.
40. Sachs-Ericsson N.J., Sawyer K.A., Corsentino E.A., Collins N.A., Blazer D.G. APOE epsilon4 allele carriers: Biological, psychological, and social variables associated with cognitive impairment. Aging Ment. Health 2010, 14:679-691.
41. Shi J., Zhao C.B., Vollmer T.L., Tyry T.M., Kuniyoshi S.M. APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis. Neurology 2008, 70:185-190.
42. Slooter A.J., Cruts M., Kalmijn S., Hofman A., Breteler M.M., Van Broeckhoven C., van Duijn C.M. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch. Neurol 1998, 55:964-968.
43. Stern Y. Cognitive reserve and Alzheimer Disease. Alzheimer Dis. Assoc. Disord 2006, 20:S69-S74.
44. Takeda M., Martínez R., Kudo T., Tanaka T., Okochi M., Tagami S., Morihara T., Hashimoto R., Cacabelos R. Apolipoprotein E and central nervous system disorders: reviews of clinical findings. Psychiatry Clin. Neurosci 2010, 64:592-607.
45. Wang H.X., Gustafson D.R., Kivipelto M., Pedersen N.L., Skoog I., Windblad B., Fratiglioni L. Education halves the risk of dementia due to apolipoprotein ε4 allele: a collaborative study from the Swedish Brain Power initiative. Neurobiol. Aging 2012, 33:1007.e1-1007.e7.
46. Wang H.X., Karp A., Winblad B., Fratiglioni L. Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: a longitudinal study from the Kungsholmen project. Am. J. Epidemiol 2002, 155:1081-1087.
47. Xu W.L., Qiu C.X., Wahlin A., Winblad B., Fratiglioni L. Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology 2004, 63:1181-1186.
48. Xu W.L., Qiu C., Winblad B., Fratiglioni L. The effect of borderline diabetes on the risk of dementia and Alzheimer's disease. Diabetes 2007, 56:211-216.
49. Xu W.L. Diabetes mellitus and the risk of dementia: a population-based study 2008, Karolinska Institutet, Accessed May 16, 2008. The frame of the thesis available at diss.kib.ki.se/2008/978-91-7357-516-4/.
50. Xu W.L., Caracciolo B., Wang H.X., Winblad B., Bäckman L., Qiu C., Fratiglioni L. Accelerated progression from mild cognitive impairment to dementia in people with diabetes. Diabetes 2010, 59:2928-2935.
51. Xu W.L., von Strauss E., Qiu C.X., Winblad B., Fratiglioni L. Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study. Diabetologia 2009, 52:1031-1039.
52. Zhu L., Fratiglioni L., Guo Z., Winblad B., Viitanen M. Incidence of stroke in relation to cognitive function and dementia in the Kungsholmen Project. Neurology 2000, 54:2103-2107.